Hepatitis B Evaluation and Linkage to Care for Newly Arrived Refugees: A Multisite Quality Improvement Initiative.
Hepatitis B
Linkage to care
Refugees
Journal
Journal of immigrant and minority health
ISSN: 1557-1920
Titre abrégé: J Immigr Minor Health
Pays: United States
ID NLM: 101256527
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
pubmed:
28
7
2020
medline:
19
8
2021
entrez:
27
7
2020
Statut:
ppublish
Résumé
A quality improvement collaborative evaluated Hepatitis B virus (HBV) care for resettled refugees and identified strategies to enhance care. 682 of the 12,934 refugees from five refugee health clinics in Colorado, Minnesota, and Pennsylvania had chronic HBV. Timely care was defined relative to a HBsAg + result: staging (HBV DNA, hepatitis Be antigen, hepatitis Be antibody, alanine transaminase testing) within 14 days, comorbid infection screening (hepatitis C virus and HIV) within 14 days, and linkage to care (HBV specialist referral within 30 days and visit within 6 months). Completed labs included: HBV DNA (93%), hepatitis Be antigen (94%), hepatitis Be antibody (92%), alanine transaminase (92%), hepatitis C screening (86%), HIV screening (97%). 20% had HBV specialist referrals within 30 days; 36% were seen within 6 months. Standardized reflex HBV testing and specialist referral should be prioritized at the initial screening due to the association with timely care.
Identifiants
pubmed: 32712852
doi: 10.1007/s10903-020-01058-7
pii: 10.1007/s10903-020-01058-7
doi:
Substances chimiques
Hepatitis B Surface Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
558-565Subventions
Organisme : CDC HHS
ID : 6 NU50CK000475-02-01
Pays : United States
Organisme : CDC HHS
ID : 5 NU50CK000459-02-00
Pays : United States
Organisme : CDC HHS
ID : 5 U50 CK000306
Pays : United States
Organisme : CDC HHS
ID : 5 U50 CK000306-S1
Pays : United States
Organisme : CDC HHS
ID : 5K23HD082312
Pays : United States
Organisme : CDC HHS
ID : 6 NU50CK000475-02-01
Pays : United States
Organisme : CDC HHS
ID : 5 NU50CK000459-02-00
Pays : United States
Organisme : CDC HHS
ID : 5 U50 CK000306
Pays : United States
Organisme : CDC HHS
ID : 5 U50 CK000306-S1
Pays : United States
Organisme : CDC HHS
ID : 5K23HD082312
Pays : United States
Références
Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1–21.
doi: 10.1016/j.cld.2009.11.009
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9.
doi: 10.1016/j.vaccine.2011.12.116
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34(6):1329–39.
doi: 10.1093/ije/dyi206
Yearbook of Immigration Statistics, 2000–2016. US Department of Homeland Security. https://www.dhs.gov/files/statistics/publications/yearbook.shtm (2017). Accessed 23 July 2020.
Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS ONE. 2012;7(9):e44611.
doi: 10.1371/journal.pone.0044611
Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56(2):422–33.
doi: 10.1002/hep.24804
Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. PLoS ONE. 2013;8(10):e78548.
doi: 10.1371/journal.pone.0078548
Scott KC, Taylor EM, Mamo B, Herr ND, Cronkright PJ, Yun K, Altshuler M, Shetty S. Hepatitis B screening and prevalence among resettled refugees—United States, 2006–2011. MMWR. 2015;64(21):570.
pubmed: 26042647
Museru OI, Vargas M, Kinyua M, Alexander KT, Franco-Paredes C, Oladele A. Hepatitis B virus infection among refugees resettled in the US: high prevalence and challenges in access to health care. J Immigr Minor Health. 2010;12(6):823–7.
doi: 10.1007/s10903-010-9335-7
Museru O, Franco-Paredes C. Epidemiology and clinical outcomes of hepatitis B virus infection among refugees seen at a US travel medicine clinic: 2005–2008. Travel Med Infect Dis. 2009;7(3):171–4.
doi: 10.1016/j.tmaid.2009.01.008
Mitruka K, Pezzi C, Baack B, Burke H, Cochran J, Matheson J, Urban K, Ramos M, Byrd K. Evaluation of hepatitis B virus screening, vaccination, and linkage to care among newly arrived refugees in four states, 2009–2011. J Immigr Minor Health. 2019;21(1):39–46.
doi: 10.1007/s10903-018-0705-x
Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99.
doi: 10.1002/hep.29800
Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A, Thomas DL. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921–6.
doi: 10.1016/S0140-6736(02)11913-1
Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18(15):2039–45.
doi: 10.1097/00002030-200410210-00008
Collins S, Mertenskoetter T, Loeliger E, Tressler R, Weller I, Friis-Møller N, Worm SW, Sabin CA, Sjøl A, Lundgren JD, Sawitz A. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166(15):1632–41.
doi: 10.1001/archinte.166.15.1632
Wilkins T, Sams R, Carpenter M. Hepatitis B: screening, prevention, diagnosis, and treatment. Am Fam Physician. 2019;99(5):314–23.
pubmed: 30811163
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(7):417–22.
doi: 10.1007/s00432-004-0552-0
CDC. General and optional testing for newly arrived refugees. https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/general/general-and-optional-tests.html (2016). Accessed 23 July 2020.
Pezzi C, Lee D, Kumar GS, Kawasaki B, Kennedy L, Aguirre J, Titus M, Ford R, Mamo B, Urban K, Hughes S. Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014–2016: a cross-sectional analysis. PLoS Med. 2020;17(3):e1003065.
doi: 10.1371/journal.pmed.1003065
Deming WE. The new economics for industry, government, education. Cambridge: MIT Press; 2018.
doi: 10.7551/mitpress/11458.001.0001
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
doi: 10.1016/j.jbi.2008.08.010
Yun K, Urban K, Mamo B, Matheson J, Payton C, Scott KC, Song L, Stauffer WM, Stone BL, Young J, Lin H. Increasing hepatitis B vaccine prevalence among refugee children arriving in the United States, 2006–2012. Am J Public Health. 2016;106(8):1460–2.
doi: 10.2105/AJPH.2016.303203
CDC. Evaluating and updating immunizations during the domestic medical examination for newly arrived refugees. https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/immunizations-guidelines.html (2016). Accessed 23 July 2020.
CDC. Screening for hepatitis during the domestic medical examination. https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/hepatitis-screening-guidelines.html (2014). Accessed 23 July 2020.
Post SE, Sodhi NK, Peng CH, Wan K, Pollack HJ. A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective. Health Aff. 2011;30(2):340–8.
doi: 10.1377/hlthaff.2008.0905
Centers for Disease Control and Prevention. Characteristics of persons with chronic hepatitis B—San Francisco, California, 2006. MMWR Morb Mortal Wkly Rep. 2007;56(18):446.
Sarkar M, Shvachko VA, Ready JB, Pauly MP, Terrault NA, Peters MG, Manos MM. Characteristics and management of patients with chronic hepatitis B in an integrated care setting. Dig Dis Sci. 2014;59(9):2100–8.
doi: 10.1007/s10620-014-3142-2
Ku KC, Li J, Ha NB, Martin M, Nguyen VG, Nguyen MH. Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics. Dig Dis Sci. 2013;58(12):3626–33.
doi: 10.1007/s10620-013-2889-1
Upadhyaya N, Chang R, Davis C, Conti MC, Salinas-Garcia D, Tang H. Chronic hepatitis B: perceptions in Asian American communities and diagnosis and management practices among primary care physicians. Postgrad Med. 2010;122(5):165–75.
doi: 10.3810/pgm.2010.09.2213
McMahon BJ. Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection. Am J Med. 2008;121(12 Suppl):S45–52.
pubmed: 19185074
Worabo HJ, Hsueh KH, Yakimo R, Worabo E, Burgess PA, Farberman SM. Understanding refugees’ perceptions of health care in the United States. J Nurse Pract. 2016;12(7):487–94.
doi: 10.1016/j.nurpra.2016.04.014
Cheng IH, Drillich A, Schattner P. Refugee experiences of general practice in countries of resettlement: a literature review. Br J Gen Pract. 2015;65(632):e171–e176176.
doi: 10.3399/bjgp15X683977
O’Leary DA, Cropp E, Isaac D, Desmond PV, Bell S, Nguyen T, Wong D, Howell J, Richmond J, O’Neill J, Thompson AJ. “B in IT”-a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool. Hepatol Med Policy. 2018;3(1):1.
doi: 10.1186/s41124-017-0031-2
Eckman MH, Kaiser TE, Sherman KE. The cost-effectiveness of screening for chronic hepatitis B infection in the United States. Clin Infect Dis. 2011;52(11):1294–306.
doi: 10.1093/cid/cir199